Infectious Mediastinitis Among the Strasbourg Universitary Hospital

University Hospital, Strasbourg, France100 enrolled

Overview

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Mediastinitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Major subject (≥18 years old) * Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020 * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research. Exclusion Criteria: * Subject having expressed opposition to participate in the study * Subject under guardianship, curatorship or safeguard of justice

Locations (1)

Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg

Time frame: Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]

Central Contacts

Yvon RUCH, MD

CONTACT

33 3 69 55 12 19 yvon.ruch@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

33 3 88 11 66 90 said.chayer@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.